Tonix Pharmaceuticals Holding Corp. share price logo

Tonix Pharmaceuticals Holding Corp. Share Price

NASDAQ: TNXP

Small Cap

$16.77

+0.46

(+2.79%)

as on

Tonix Pharmaceuticals Holding Corp. Stock Performance

as on November 20, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $16.6
    $18.25
    downward going graph

    1.01%

    Downside

    8.83%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.76
    $130
    downward going graph

    59.69%

    Downside

    675.19%

    Upside

    downward going graph

Tonix Pharmaceuticals Holding Corp. share price movements today

Previous Close
$16.31
Open
$17.30
Volume
1.2M
Day's Low - High
$16.6 - $18.25
52 Week Low - High
$6.76 - $130

Tonix Pharmaceuticals Holding Corp. Historical Returns

1 Month Return
-15.73 %
3 Month Return
-53.62 %
1 Year Return
-12 %
3 Year Return
-99.8 %
5 Year Return
-100 %

Tonix Pharmaceuticals Holding Corp. Stock Fundamentals & Key Indicators

Check Tonix Pharmaceuticals Holding Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$190.2M

EPS (TTM)

-10.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.06

Industry PE ratio

-0.8126129032258065

PEG Ratio

0

EBITDA

-97.5M

Revenue (TTM)

10.3M

Profit Margin

0.00%

Return On Equity TTM

-64.99%

Tonix Pharmaceuticals Holding Corp. Stock Valuation

Track how Tonix Pharmaceuticals Holding Corp. P/E has moved over time to understand its valuation trends.

Tonix Pharmaceuticals Holding Corp. in the last 5 years

  • Overview

  • Trends

Lowest (-194.10x)

March 31, 2024

Industry (-0.81x)

November 20, 2025

Today (0.06x)

November 20, 2025

Highest (-0.64x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.06x

Tonix Pharmaceuticals Holding Corp. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tonix Pharmaceuticals Holding Corp. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Tonix Pharmaceuticals Holding Corp. image
Tonix Pharmaceuticals Holding Corp.
BUY$190.2M-100%0.060.00%
Insmed Incorporated image
Insmed Incorporated
BUY$43.4B421.01%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B269.49%1651.071.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.7B95.64%30.6731.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$76.9B35.47%17.3932.13%

Stock Returns calculator for Tonix Pharmaceuticals Holding Corp. Stock including INR - Dollar returns

The Tonix Pharmaceuticals Holding Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tonix Pharmaceuticals Holding Corp. investment value today

Current value as on today

₹93,339

Returns

₹6,661

(-6.66%)

Returns from Tonix Pharmaceuticals Holding Corp. Stock

₹11,737 (-11.74%)

Dollar Returns*

₹5,076 (+5.08%)

Analyst Recommendation on Tonix Pharmaceuticals Holding Corp. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Tonix Pharmaceuticals Holding Corp.. Average target price of $67.67

Tonix Pharmaceuticals Holding Corp. Share Price Target

Get share price movements and forecasts by analysts on Tonix Pharmaceuticals Holding Corp..

What analysts predicted

75.22%UPSIDE

Target Price

$67.67

Current Price

$16.77

Analyzed by

8 Analysts

Target

$67.67

Tonix Pharmaceuticals Holding Corp. target price $67.67, a slight upside of 75.22% compared to current price of $16.77. According to 8 analysts rating.

Tonix Pharmaceuticals Holding Corp. Stock’s Investor Sentiment and Interest

Investment in Tonix Pharmaceuticals Holding Corp. Shares on INDmoney has dropped by -27.83% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-27.83% versus previous 30 day period

Search interest for Tonix Pharmaceuticals Holding Corp. Stock has increased by 91% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:91% versus previous 30 day period

Tonix Pharmaceuticals Holding Corp. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
3
3
2
2
2
2
2
1
3
Gross Profit
-29
1
1
0
-1
1
1
1
-1
1
Operating Income
-29
-28
-27
-21
-18
-15
-22
-16
-28
-33
EBITDA
-28
-27
-
-20
-17
-15
-21
-16
-27
-31
Interest Expense
-
-
-
1
-
0
-
-
-
-
Depreciation
0
1
1
1
1
0
0
0
0
0
Income Before Tax
-28
-27
-27
-14
-78
-14
-22
-16
-28
-32
Income Tax Expense
29
-1
-
-1
-
-
0
-
-
-
Net Income
-28
-27
-27
-14
-78
-14
-22
-16
-28
-32
Net Profit Margin
0.00%
-701.30%
-723.00%
-601.89%
-3567.75%
-503.65%
-856.24%
-692.84%
-1415.02%
-972.95%

Tonix Pharmaceuticals Holding Corp. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
2
-
9
7
10
Gross Profit
-48
-38
-21
-26
-28
-50
-92
-112
3
2
Operating Income
-48
-38
-21
-26
-28
-50
-92
-112
-118
-136
EBITDA
-48
-38
-21
-26
-28
-50
-92
-110
-114
-74
Interest Expense
-
-
-
-
-
-
0
7
-
-
Depreciation
-
-
0
0
0
0
0
1
3
3
Income Before Tax
-48
-38
-21
-26
-28
-50
-92
-110
-116
-130
Income Tax Expense
0
0
0
0
0
0
0
4
0
-1
Net Income
-48
-38
-21
-26
-28
-50
-92
-115
-116
-130
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-1729.17%
0.00%
-1274.00%
-1501.78%
-1288.25%

Tonix Pharmaceuticals Holding Corp. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-27
-27
-14
-78
-14
-22
-16
-28
-32
Operating Cash Flow
-23
-22
-17
-9
-18
-14
-16
-14
-28
Investing Cash Flow
0
-
0
0
0
0
0
-2
0
Financing Cash Flow
6
40
0
7
42
85
49
10
94
Change in Cash
-17
17
-17
-2
24
70
32
-6
65

Tonix Pharmaceuticals Holding Corp. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-38
-21
-26
-28
-50
-92
-110
-116
-130
Operating Cash Flow
-37
-19
-23
-26
-48
-75
-98
-102
-60
Investing Cash Flow
16
7
0
0
-8
-35
-48
-29
0
Financing Cash Flow
20
18
23
12
123
212
87
36
134
Change in Cash
0
6
0
-13
65
101
-58
-94
73

Global Institutional Holdings in Tonix Pharmaceuticals Holding Corp.

Funds
Holdings
BlackRock Inc
4.8%
Geode Capital Management, LLC
2%
Vanguard Group Inc
1.88%
Northern Trust Corp
1.87%
State Street Corp
1.41%
See all

Insights on Tonix Pharmaceuticals Holding Corp.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TNXP stock has moved up by 3.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.99M → 3.29M (in $), with an average increase of 39.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 943.9% return, outperforming this stock by 1043.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 180.1% return, outperforming this stock by 192.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -16.82M → -32.00M (in $), with an average decrease of 40.6% per quarter

About Tonix Pharmaceuticals Holding Corp.

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.
OrganisationTonix Pharmaceuticals Holding Corp.
Headquarters26 Main Street, Chatham, NJ, United States, 07928
IndustryHealth Technology
CEODr. Seth Lederman M.D.
E-voting on sharesClick here to vote

Key Management of Tonix Pharmaceuticals Holding Corp.

Name

Title

Mr. Bradley Saenger CPA

CFO & Treasurer

Dr. Darryl Rideout Ph.D.

Executive Vice President of Experimental Chemistry

Dr. Sina Bavari Ph.D.

Executive Vice President of Infectious Disease Research & Development

Mr. Thomas Englese M.B.A.

Executive Vice President of Commercial Operations

Dr. Seth Lederman M.D.

Co-Founder, President, CEO & Chairman

Dr. Gregory M. Sullivan M.D.

Chief Medical Officer & Secretary

Ms. Siobhan Fogarty B.Sc., M.Sc.

Chief Technical Officer

Mr. Joseph Hand Esq., J.D.

General Counsel & Executive VP of Operations

Dr. Zeil Rosenberg M.D., M.P.H.

Executive Vice President of Medical

Mrs. Jessica Edgar Morris

Chief Operating Officer

FAQs

What is Tonix Pharmaceuticals Holding Corp. share price today?

Tonix Pharmaceuticals Holding Corp. share price today is $16.77 as on at the close of the market. Tonix Pharmaceuticals Holding Corp. share today touched a day high of $18.25 and a low of $16.6.

What is the 52 week high and 52 week low for Tonix Pharmaceuticals Holding Corp. share?

Tonix Pharmaceuticals Holding Corp. share touched a 52 week high of $130 on and a 52 week low of $6.76 on . Tonix Pharmaceuticals Holding Corp. stock price today i.e. is closed at $16.77,which is 87.10% down from its 52 week high and 148.08% up from its 52 week low.

What is Tonix Pharmaceuticals Holding Corp.'s market capitalisation today?

Tonix Pharmaceuticals Holding Corp. market capitalisation is $0.00T as on .

How to invest in Tonix Pharmaceuticals Holding Corp. Stock (TNXP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tonix Pharmaceuticals Holding Corp. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tonix Pharmaceuticals Holding Corp. Shares that will get you 0.0894 shares as per Tonix Pharmaceuticals Holding Corp. share price of $16.77 per share as on November 20, 2025 at 2:29 am IST.

What is the minimum amount required to buy Tonix Pharmaceuticals Holding Corp. Stock (TNXP) from India?

Indian investors can start investing in Tonix Pharmaceuticals Holding Corp. (TNXP) shares with as little as ₹88.6 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.00 in Tonix Pharmaceuticals Holding Corp. stock (as per the Rupee-Dollar exchange rate as on ). Based on Tonix Pharmaceuticals Holding Corp. share’s latest price of $16.77 as on November 20, 2025 at 2:29 am IST, you will get 0.5963 shares of Tonix Pharmaceuticals Holding Corp.. Learn more about fractional shares .

What are the returns that Tonix Pharmaceuticals Holding Corp. has given to Indian investors in the last 5 years?

Tonix Pharmaceuticals Holding Corp. stock has given -100% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?